A drug and animal model for the intervention of skin photoaging caused by UVA

A technology for skin photoaging and effect, applied in drug combinations, skin diseases, animal cells, etc., can solve problems such as unclear and unrealized effects

Active Publication Date: 2021-07-27
GUANGZHOU CENT FOR DISEASE CONTROL & PREVENTION (GUANGZHOU HYGIENE INSPECTION CENT GUANGZHOU CENT FOR FOOD SAFETY RISK SURVEILLANCE & ASSESSMENT INST OF PUBLIC HEALTH OF GUANGZHOU MEDICAL UNIV) +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether I3C can prevent or delay photoaging through this pathway is still unclear
[0008] Through the above analysis, the problems and defects of the existing technology are: the existing technology is mainly used to solve the chemopreventive effect of various tumors, and has not yet realized its role in preventing, delaying and weakening the photoaging effect caused by ultraviolet rays; whether I3C can Protecting cells, reducing damage, or delaying photoaging through anti-oxidative stress and anti-inflammatory responses is not yet clear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A drug and animal model for the intervention of skin photoaging caused by UVA
  • A drug and animal model for the intervention of skin photoaging caused by UVA
  • A drug and animal model for the intervention of skin photoaging caused by UVA

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0077] In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.

[0078] Aiming at the problems existing in the prior art, the present invention provides a drug and an animal model for intervening in UVA-induced skin photoaging. The present invention will be described in detail below with reference to the accompanying drawings.

[0079] The medicine provided in the embodiment of the present invention for the intervention of UVA-induced skin photoaging is indole-3-carbinol, and the maximum non-effect dose on HaCaT cells is 10 μmol / L.

[0080] Such as figure 1As shown, the method for constructing an animal model of a drug for the intervention effect of UVA-induced skin photoaging provided ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of pharmaceutical preparations, and discloses a drug and an animal model for intervening skin photoaging caused by UVA. The drug is indole-3-methanol, and the maximum non-effect dose on HaCaT cells is 10 μmol / L. Take HaCaT cells in the logarithmic growth phase, press 2×10 5 Each well was inoculated in a 6-well culture plate and cultured in a cell culture incubator until the cell confluence was 70-80%; it was divided into groups as follows: the blank control group was covered with opaque black paper, and the UVA model group The irradiation dose is 1J / cm 2 , the I3C treatment group was also treated with 10 μmol / L I3C while irradiating UVA, and two parallel samples were set for each dose; after the irradiation, the changes in the number and shape of cells were observed. The invention can improve the lesions of mouse skin epidermal cells and fibrous tissue caused by excessive UVA irradiation, thus delaying the formation of skin photoaging.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a drug and an animal model for interfering with UVA-induced skin photoaging. Background technique [0002] Human skin aging is a very complicated process, and genetic factors and environmental factors affect it at the same time. At present, it is found that ultraviolet rays in environmental factors are an important cause of skin aging. Human skin is exposed to ultraviolet radiation from sunlight every day. Studies have shown that long-term ultraviolet radiation will lead to skin photoaging and even skin cancer. With the improvement of human living standards and the growth of the aging population, the problem of skin aging has increasingly attracted people's attention. Due to the increasing destruction of the atmospheric ozone layer and living habits, skin photoaging has become one of the important health problems that threaten modern humans. The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/40A61P17/18C12N5/071C12N13/00G01N33/573
CPCA61K31/40A61P17/18C12N5/0625C12N13/00G01N33/573
Inventor 朱伟叶兴东殷花杨光宇李文学张岩李军涛杨智聪
Owner GUANGZHOU CENT FOR DISEASE CONTROL & PREVENTION (GUANGZHOU HYGIENE INSPECTION CENT GUANGZHOU CENT FOR FOOD SAFETY RISK SURVEILLANCE & ASSESSMENT INST OF PUBLIC HEALTH OF GUANGZHOU MEDICAL UNIV)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products